Business Description
Enzolytics Inc
NAICS : 325412
SIC : 2834
ISIN : US2941121079
Compare
Compare
Traded in other countries / regions
ENZC.USA IPO Date
2008-07-15Description
Enzolytics Inc is a biotechnology company, whose products consist of multiple distinct drug development proprietary technologies: Immunotherapy, immune modulators, fully human monoclonal antibodies, and an artificial intelligence (AI) platform for health care developments. It has clinically tested anti-HIV therapeutics. Additionally, the Company has created a proprietary cell line that produces fully human monoclonal antibodies that target and neutralizes the HIV virus.
Financial Strength
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 24.66 | |||||
| 9-Day RSI | 26.16 | |||||
| 14-Day RSI | 29.21 | |||||
| 6-1 Month Momentum % | -54.39 | |||||
| 12-1 Month Momentum % | -74 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| FCF Margin % | -758.7 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | -11.1 | |||||
| EV-to-EBITDA | -11.12 | |||||
| EV-to-Revenue | 1555.98 | |||||
| Earnings Yield (Greenblatt) % | -9.01 | |||||
| FCF Yield % | -3.49 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:ENZC
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Enzolytics Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.046 | ||
| EPS (TTM) ($) | -170.268 | ||
| Beta | -0.09 | ||
| Volatility % | 68.94 | ||
| 14-Day RSI | 29.21 | ||
| 14-Day ATR ($) | 0.001888 | ||
| 20-Day SMA ($) | 0.008997 | ||
| 12-1 Month Momentum % | -74 | ||
| 52-Week Range ($) | 0.0038 - 0.132 | ||
| Shares Outstanding (Mil) | 2,438.67 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Enzolytics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Enzolytics Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Enzolytics Inc Frequently Asked Questions
What is Enzolytics Inc(ENZC)'s stock price today?
The current price of ENZC is $0.00. The 52 week high of ENZC is $0.13 and 52 week low is $0.00.
When is next earnings date of Enzolytics Inc(ENZC)?
The next earnings date of Enzolytics Inc(ENZC) is 2024-05-22 Est..
Does Enzolytics Inc(ENZC) pay dividends? If so, how much?
Enzolytics Inc(ENZC) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers